Women with atrial fibrillation: Greater risk, less attention
Authors:
- Annabelle S. VolgmanAVAnnabelle S. Volgman
- Marian F. ManankilMMMarian F. Manankil
- Disha MookherjeeDMDisha Mookherjee
- Richard G. TrohmanRTRichard G. Trohman
- 1 September 2009
- journal article
- review article
- Published by Elsevier in Gender Medicine
- Vol. 6 (3) , 419-432
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- A Randomized Trial of Rosuvastatin in the Prevention of Venous ThromboembolismNew England Journal of Medicine, 2009
- Alcohol Consumption and Risk of Incident Atrial Fibrillation in WomenJAMA, 2008
- C-Reactive Protein Levels and Atrial Fibrillation After Cardiac Surgery in WomenThe Annals of Thoracic Surgery, 2006
- The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) TrialAmerican Heart Journal, 2006
- Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesEuropean Heart Journal, 2005
- Clinical factors that influence response to treatment strategies in atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) StudyAmerican Heart Journal, 2005
- Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversionThe American Journal of Cardiology, 2004
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionNew England Journal of Medicine, 1999
- Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.The American Journal of Cardiology, 1998
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989